Drug Profile


Alternative Names: Anaprazole sodium - Sihuan

Latest Information Update: 29 Oct 2014

Price : $50

At a glance

  • Originator Sihuan Pharmaceutical Holdings Group
  • Class Antiulcers
  • Mechanism of Action Proton pump inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

  • New Molecular Entity Yes

Highest Development Phases

  • Phase I Gastrointestinal ulcer

Most Recent Events

  • 30 Jun 2014 Phase-I clinical trials in Gastrointestinal ulcer in China (PO)
  • 17 Jul 2013 Preclinical trials in Gastrointestinal ulcer in China (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top